Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Operating Leases (2019 - 2025)

Catheter Precision (VTAK) has disclosed Operating Leases for 7 consecutive years, with $101000.0 as the latest value for Q4 2025.

  • Quarterly Operating Leases rose 676.92% to $101000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $101000.0 through Dec 2025, up 676.92% year-over-year, with the annual reading at $101000.0 for FY2025, 676.92% up from the prior year.
  • Operating Leases for Q4 2025 was $101000.0 at Catheter Precision, down from $114000.0 in the prior quarter.
  • The five-year high for Operating Leases was $2.2 million in Q1 2021, with the low at $3000.0 in Q1 2025.
  • Average Operating Leases over 5 years is $735166.7, with a median of $147000.0 recorded in 2024.
  • Peak annual rise in Operating Leases hit 676.92% in 2025, while the deepest fall reached 98.33% in 2025.
  • Over 5 years, Operating Leases stood at $2.0 million in 2021, then fell by 11.86% to $1.7 million in 2022, then plummeted by 94.44% to $97000.0 in 2023, then plummeted by 86.6% to $13000.0 in 2024, then surged by 676.92% to $101000.0 in 2025.
  • According to Business Quant data, Operating Leases over the past three periods came in at $101000.0, $114000.0, and $94000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.